Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > My takeaway on latest interview

<< Previous

Bullboard Posts

Next >>

Comment by Stockfshron Feb 17, 2022 11:55pm

183 Views

Post# 34440692

RE:My takeaway on latest interview

Also, towards the end of 2022, look for updates on progress towards a new clinical indication on thyroid disease. Yes, I am pumped. Regenerative medicine should be a huge market, I think. The best investing and the best reward is to help people who are struggling through no fault of their own. This is my best pick to do just that. Best of luck to us all.

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia